Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 57 entries
Sorted by: Best Match Show Resources per page
Does prevention pay?.

Medical care

Meltzer D.
PMID: 25769054
Med Care. 2015 Apr;53(4):291-2. doi: 10.1097/MLR.0000000000000353.

No abstract available.

Cite
Meltzer D. Does prevention pay?. Med Care. 2015;53(4):291-2doi: 10.1097/MLR.0000000000000353.
Meltzer, D. (2015). Does prevention pay?. Medical care, 53(4), 291-2. https://doi.org/10.1097/MLR.0000000000000353
Meltzer, David. "Does prevention pay?." Medical care vol. 53,4 (2015): 291-2. doi: https://doi.org/10.1097/MLR.0000000000000353
Meltzer D. Does prevention pay?. Med Care. 2015 Apr;53(4):291-2. doi: 10.1097/MLR.0000000000000353. PMID: 25769054.
Copy Download .nbib Format: NLM
Hospitalists and primary care.

Journal of general internal medicine

Meltzer DO.
PMID: 25731915
J Gen Intern Med. 2015 May;30(5):541-2. doi: 10.1007/s11606-015-3246-1.

No abstract available.

Cite
Meltzer DO. Hospitalists and primary care. J Gen Intern Med. 2015;30(5):541-2doi: 10.1007/s11606-015-3246-1.
Meltzer, D. O. (2015). Hospitalists and primary care. Journal of general internal medicine, 30(5), 541-2. https://doi.org/10.1007/s11606-015-3246-1
Meltzer, David O. "Hospitalists and primary care." Journal of general internal medicine vol. 30,5 (2015): 541-2. doi: https://doi.org/10.1007/s11606-015-3246-1
Meltzer DO. Hospitalists and primary care. J Gen Intern Med. 2015 May;30(5):541-2. doi: 10.1007/s11606-015-3246-1. PMID: 25731915; PMCID: PMC4395593.
Copy Download .nbib Format: NLM
A qualitative analysis of patients' experience with hospitalist service handovers.

Journal of hospital medicine

Wray CM, Farnan JM, Arora VM, Meltzer DO.
PMID: 27167097
J Hosp Med. 2016 Oct;11(10):675-681. doi: 10.1002/jhm.2608. Epub 2016 May 11.

BACKGROUND: Inpatient service handoffs occur when physicians who care for hospitalized patients end a period of clinical service and handover a panel of patients to an oncoming physician. Despite the large amount of research on handoffs, none has described...

Cite
Wray CM, Farnan JM, Arora VM, et al. A qualitative analysis of patients' experience with hospitalist service handovers. J Hosp Med. 2016;11(10):675-681doi: 10.1002/jhm.2608.
Wray, C. M., Farnan, J. M., Arora, V. M., & Meltzer, D. O. (2016). A qualitative analysis of patients' experience with hospitalist service handovers. Journal of hospital medicine, 11(10), 675-681. https://doi.org/10.1002/jhm.2608
Wray, Charlie M, et al. "A qualitative analysis of patients' experience with hospitalist service handovers." Journal of hospital medicine vol. 11,10 (2016): 675-681. doi: https://doi.org/10.1002/jhm.2608
Wray CM, Farnan JM, Arora VM, Meltzer DO. A qualitative analysis of patients' experience with hospitalist service handovers. J Hosp Med. 2016 Oct;11(10):675-681. doi: 10.1002/jhm.2608. Epub 2016 May 11. PMID: 27167097.
Copy Download .nbib Format: NLM
Patient Characteristics Associated with and Changes Over Time in Trust in Inpatient Physicians.

Journal of general internal medicine

Prochaska MT, Zhang H, Meltzer DO, Arora VM.
PMID: 33634381
J Gen Intern Med. 2021 Feb 25; doi: 10.1007/s11606-021-06649-0. Epub 2021 Feb 25.

No abstract available.

Cite
Prochaska MT, Zhang H, Meltzer DO, et al. Patient Characteristics Associated with and Changes Over Time in Trust in Inpatient Physicians. J Gen Intern Med. 2021;doi: 10.1007/s11606-021-06649-0.
Prochaska, M. T., Zhang, H., Meltzer, D. O., & Arora, V. M. (2021). Patient Characteristics Associated with and Changes Over Time in Trust in Inpatient Physicians. Journal of general internal medicine, . https://doi.org/10.1007/s11606-021-06649-0
Prochaska, Micah T, et al. "Patient Characteristics Associated with and Changes Over Time in Trust in Inpatient Physicians." Journal of general internal medicine vol. (2021). doi: https://doi.org/10.1007/s11606-021-06649-0
Prochaska MT, Zhang H, Meltzer DO, Arora VM. Patient Characteristics Associated with and Changes Over Time in Trust in Inpatient Physicians. J Gen Intern Med. 2021 Feb 25; doi: 10.1007/s11606-021-06649-0. Epub 2021 Feb 25. PMID: 33634381.
Copy Download .nbib Format: NLM
The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System.

Journal of personalized medicine

David SP, Singh L, Pruitt J, Hensing A, Hulick P, Meltzer DO, O'Donnell PH, Dunnenberger HM.
PMID: 34945714
J Pers Med. 2021 Nov 23;11(12). doi: 10.3390/jpm11121242.

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines exist for many medications commonly prescribed prior to hospital discharge, yet there are limited data regarding the contribution of gene-x-drug interactions to hospital readmissions. The present study evaluated the relationship between prescription of...

Cite
David SP, Singh L, Pruitt J, et al. The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System. J Pers Med. 2021;11(12)doi: 10.3390/jpm11121242.
David, S. P., Singh, L., Pruitt, J., Hensing, A., Hulick, P., Meltzer, D. O., O'Donnell, P. H., & Dunnenberger, H. M. (2021). The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System. Journal of personalized medicine, 11(12), . https://doi.org/10.3390/jpm11121242
David, Sean P, et al. "The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System." Journal of personalized medicine vol. 11,12 (2021). doi: https://doi.org/10.3390/jpm11121242
David SP, Singh L, Pruitt J, Hensing A, Hulick P, Meltzer DO, O'Donnell PH, Dunnenberger HM. The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System. J Pers Med. 2021 Nov 23;11(12). doi: 10.3390/jpm11121242. PMID: 34945714; PMCID: PMC8705172.
Copy Download .nbib Format: NLM
Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients.

Journal of personalized medicine

Saulsberry L, Danahey K, Middlestadt M, O'Leary KJ, Nutescu EA, Chen T, Lee JC, Ruhnke GW, George D, House L, van Wijk XMR, Yeo KJ, Choksi A, Hartman SW, Knoebel RW, Friedman PN, Rasmussen LV, Ratain MJ, Perera MA, Meltzer DO, O'Donnell PH.
PMID: 34945816
J Pers Med. 2021 Dec 10;11(12). doi: 10.3390/jpm11121343.

Known disparities exist in the availability of pharmacogenomic information for minority populations, amplifying uncertainty around clinical utility for these groups. We conducted a multi-site inpatient pharmacogenomic implementation program among self-identified African-Americans (AA;

Cite
Saulsberry L, Danahey K, Middlestadt M, et al. Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients. J Pers Med. 2021;11(12)doi: 10.3390/jpm11121343.
Saulsberry, L., Danahey, K., Middlestadt, M., O'Leary, K. J., Nutescu, E. A., Chen, T., Lee, J. C., Ruhnke, G. W., George, D., House, L., van Wijk, X. M. R., Yeo, K. J., Choksi, A., Hartman, S. W., Knoebel, R. W., Friedman, P. N., Rasmussen, L. V., Ratain, M. J., Perera, M. A., Meltzer, D. O., & O'Donnell, P. H. (2021). Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients. Journal of personalized medicine, 11(12), . https://doi.org/10.3390/jpm11121343
Saulsberry, Loren, et al. "Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients." Journal of personalized medicine vol. 11,12 (2021). doi: https://doi.org/10.3390/jpm11121343
Saulsberry L, Danahey K, Middlestadt M, O'Leary KJ, Nutescu EA, Chen T, Lee JC, Ruhnke GW, George D, House L, van Wijk XMR, Yeo KJ, Choksi A, Hartman SW, Knoebel RW, Friedman PN, Rasmussen LV, Ratain MJ, Perera MA, Meltzer DO, O'Donnell PH. Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients. J Pers Med. 2021 Dec 10;11(12). doi: 10.3390/jpm11121343. PMID: 34945816.
Copy Download .nbib Format: NLM
Corrigendum to: The Longevity-Associated SH2B3 (LNK) Genetic Variant: Selected Aging Phenotypes in 379,758 Subjects.

The journals of gerontology. Series A, Biological sciences and medical sciences

Kuo CL, Joaquim M, Kuchel GA, Ferrucci L, Harries LW, Pilling LC, Melzer D.
PMID: 31783406
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1686. doi: 10.1093/gerona/glz268.

No abstract available.

Cite
Kuo CL, Joaquim M, Kuchel GA, et al. Corrigendum to: The Longevity-Associated SH2B3 (LNK) Genetic Variant: Selected Aging Phenotypes in 379,758 Subjects. J Gerontol A Biol Sci Med Sci. 2020;75(9):1686doi: 10.1093/gerona/glz268.
Kuo, C. L., Joaquim, M., Kuchel, G. A., Ferrucci, L., Harries, L. W., Pilling, L. C., & Melzer, D. (2020). Corrigendum to: The Longevity-Associated SH2B3 (LNK) Genetic Variant: Selected Aging Phenotypes in 379,758 Subjects. The journals of gerontology. Series A, Biological sciences and medical sciences, 75(9), 1686. https://doi.org/10.1093/gerona/glz268
Kuo, Chia-Ling, et al. "Corrigendum to: The Longevity-Associated SH2B3 (LNK) Genetic Variant: Selected Aging Phenotypes in 379,758 Subjects." The journals of gerontology. Series A, Biological sciences and medical sciences vol. 75,9 (2020): 1686. doi: https://doi.org/10.1093/gerona/glz268
Kuo CL, Joaquim M, Kuchel GA, Ferrucci L, Harries LW, Pilling LC, Melzer D. Corrigendum to: The Longevity-Associated SH2B3 (LNK) Genetic Variant: Selected Aging Phenotypes in 379,758 Subjects. J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1686. doi: 10.1093/gerona/glz268. PMID: 31783406; PMCID: PMC8177806.
Copy Download .nbib Format: NLM
Opportunities in the Economics of Personalized Health Care and Prevention.

Forum for health economics & policy

Meltzer DO.
PMID: 31419870
Forum Health Econ Policy. 2013 Sep 01;16(2):S13-S22. doi: 10.1515/fhep-2013-0012.

Personalized medicine is best viewed from a broad perspective of trying to use information about a patient to improve care. While "personalized medicine" often emphasizes the value of genetic information, traditional clinical approaches to personalizing care based on patient...

Cite
Meltzer DO. Opportunities in the Economics of Personalized Health Care and Prevention. Forum Health Econ Policy. 2013;16(2):S13-S22doi: 10.1515/fhep-2013-0012.
Meltzer, D. O. (2013). Opportunities in the Economics of Personalized Health Care and Prevention. Forum for health economics & policy, 16(2), S13-S22. https://doi.org/10.1515/fhep-2013-0012
Meltzer, David O. "Opportunities in the Economics of Personalized Health Care and Prevention." Forum for health economics & policy vol. 16,2 (2013): S13-S22. doi: https://doi.org/10.1515/fhep-2013-0012
Meltzer DO. Opportunities in the Economics of Personalized Health Care and Prevention. Forum Health Econ Policy. 2013 Sep 01;16(2):S13-S22. doi: 10.1515/fhep-2013-0012. PMID: 31419870.
Copy Download .nbib Format: NLM
Risk factors for cost-related medication non-adherence among older patients with cancer.

Integrative cancer science and therapeutics

Zhang JX, Meltzer DO.
PMID: 27087984
Integr Cancer Sci Ther. 2015 Dec;2(6):300-304. Epub 2015 Nov 06.

We aimed to assess the risk factors for cost-related medication non-adherence (CRN) among older patients with cancer in the United States. We used data from the 2010 Health and Retirement Study (HRS) to assess risk factors for CRN including...

Cite
Zhang JX, Meltzer DO. Risk factors for cost-related medication non-adherence among older patients with cancer. Integr Cancer Sci Ther. 2015;2(6):300-304
Zhang, J. X., & Meltzer, D. O. (2015). Risk factors for cost-related medication non-adherence among older patients with cancer. Integrative cancer science and therapeutics, 2(6), 300-304.
Zhang, James X, and Meltzer, David O. "Risk factors for cost-related medication non-adherence among older patients with cancer." Integrative cancer science and therapeutics vol. 2,6 (2015): 300-304.
Zhang JX, Meltzer DO. Risk factors for cost-related medication non-adherence among older patients with cancer. Integr Cancer Sci Ther. 2015 Dec;2(6):300-304. Epub 2015 Nov 06. PMID: 27087984; PMCID: PMC4827776.
Copy Download .nbib Format: NLM
Toward a science of research prioritization? The use of value of information by multidisciplinary stakeholder groups.

Medical decision making : an international journal of the Society for Medical Decision Making

Fleurence RL, Meltzer DO.
PMID: 23635832
Med Decis Making. 2013 May;33(4):460-2. doi: 10.1177/0272989X13486979.

No abstract available.

Cite
Fleurence RL, Meltzer DO. Toward a science of research prioritization? The use of value of information by multidisciplinary stakeholder groups. Med Decis Making. 2013;33(4):460-2doi: 10.1177/0272989X13486979.
Fleurence, R. L., & Meltzer, D. O. (2013). Toward a science of research prioritization? The use of value of information by multidisciplinary stakeholder groups. Medical decision making : an international journal of the Society for Medical Decision Making, 33(4), 460-2. https://doi.org/10.1177/0272989X13486979
Fleurence, Rachael L, and Meltzer, David O. "Toward a science of research prioritization? The use of value of information by multidisciplinary stakeholder groups." Medical decision making : an international journal of the Society for Medical Decision Making vol. 33,4 (2013): 460-2. doi: https://doi.org/10.1177/0272989X13486979
Fleurence RL, Meltzer DO. Toward a science of research prioritization? The use of value of information by multidisciplinary stakeholder groups. Med Decis Making. 2013 May;33(4):460-2. doi: 10.1177/0272989X13486979. PMID: 23635832.
Copy Download .nbib Format: NLM
The distribution of the common mental disorders: social inequalities in Europe.

Clinical practice and epidemiology in mental health : CP & EMH

Fryers T, Melzer D, Jenkins R, Brugha T.
PMID: 16143042
Clin Pract Epidemiol Ment Health. 2005 Sep 05;1:14. doi: 10.1186/1745-0179-1-14.

BACKGROUND: The social class distribution of the common mental disorders (mostly anxiety and/or depression) has been in doubt until recently. This paper reviews the evidence of associations between the prevalence of the common mental disorders in adults of working...

Cite
Fryers T, Melzer D, Jenkins R, et al. The distribution of the common mental disorders: social inequalities in Europe. Clin Pract Epidemiol Ment Health. 2005;1:14doi: 10.1186/1745-0179-1-14.
Fryers, T., Melzer, D., Jenkins, R., & Brugha, T. (2005). The distribution of the common mental disorders: social inequalities in Europe. Clinical practice and epidemiology in mental health : CP & EMH, 114. https://doi.org/10.1186/1745-0179-1-14
Fryers, Tom, et al. "The distribution of the common mental disorders: social inequalities in Europe." Clinical practice and epidemiology in mental health : CP & EMH vol. 1 (2005): 14. doi: https://doi.org/10.1186/1745-0179-1-14
Fryers T, Melzer D, Jenkins R, Brugha T. The distribution of the common mental disorders: social inequalities in Europe. Clin Pract Epidemiol Ment Health. 2005 Sep 05;1:14. doi: 10.1186/1745-0179-1-14. PMID: 16143042; PMCID: PMC1242241.
Copy Download .nbib Format: NLM
Training and career development for comparative effectiveness research workforce development: CTSA Consortium Strategic Goal Committee on comparative effectiveness research workgroup on workforce development.

Clinical and translational science

Kroenke K, Kapoor W, Helfand M, Meltzer DO, McDonald MA, Selker H.
PMID: 20973924
Clin Transl Sci. 2010 Oct;3(5):258-62. doi: 10.1111/j.1752-8062.2010.00221.x.

As comparative effectiveness research (CER) increasingly becomes a national priority, there are increased needs for training and workforce development in this area. Particularly important CER competencies include clinical epidemiology, biomedical informatics, economic analyses, systematic reviews, clinical practice guideline development,...

Cite
Kroenke K, Kapoor W, Helfand M, et al. Training and career development for comparative effectiveness research workforce development: CTSA Consortium Strategic Goal Committee on comparative effectiveness research workgroup on workforce development. Clin Transl Sci. 2010;3(5):258-62doi: 10.1111/j.1752-8062.2010.00221.x.
Kroenke, K., Kapoor, W., Helfand, M., Meltzer, D. O., McDonald, M. A., & Selker, H. (2010). Training and career development for comparative effectiveness research workforce development: CTSA Consortium Strategic Goal Committee on comparative effectiveness research workgroup on workforce development. Clinical and translational science, 3(5), 258-62. https://doi.org/10.1111/j.1752-8062.2010.00221.x
Kroenke, Kurt, et al. "Training and career development for comparative effectiveness research workforce development: CTSA Consortium Strategic Goal Committee on comparative effectiveness research workgroup on workforce development." Clinical and translational science vol. 3,5 (2010): 258-62. doi: https://doi.org/10.1111/j.1752-8062.2010.00221.x
Kroenke K, Kapoor W, Helfand M, Meltzer DO, McDonald MA, Selker H. Training and career development for comparative effectiveness research workforce development: CTSA Consortium Strategic Goal Committee on comparative effectiveness research workgroup on workforce development. Clin Transl Sci. 2010 Oct;3(5):258-62. doi: 10.1111/j.1752-8062.2010.00221.x. PMID: 20973924; PMCID: PMC2965561.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 57 entries